Article Details

Akeso to Present Data from 13 Clinical Studies at ESMO 2024, Featuring its ... - PR Newswire Asia

Retrieved on: 2024-09-06 00:58:36

Tags for this article:

Click the tags to see associated articles and topics

Akeso to Present Data from 13 Clinical Studies at ESMO 2024, Featuring its ... - PR Newswire Asia. View article details on hiswai:

Excerpt

... antibody cadonilimab, PD-1/VEGF bispecific antibody ivonescimab, next-generation CD47 monoclonal antibody ligufalimab, and commercially available ...

Article found on: en.prnasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo